The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype

Fojo, T., LaRose, M., & Bates, S. E. (2024). The Impact of Exuberance on Equipoise in Oncology Clinical Trials: Sotorasib as Archetype. The Oncologist, 29(4), 275–277. https://doi.org/10.1093/oncolo/oyae042
Authors:
Tito Fojo
Meredith LaRose
Susan E. Bates
Affiliated Authors:
Tito Fojo
Meredith LaRose
Susan E. Bates
Columbia Affiliation:
Subjects:
Piperazines (MeSH)
Pyridines (MeSH)
Drug Approval (MeSH)
Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapy (OpenAlex Topic)
Genomic Landscape of Cancer and Mutational Signatures (OpenAlex Topic)
Statistical Methods in Clinical Trials and Drug Development (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1093/oncolo/oyae042
PMID:
38498045
DOI:
10.1093/oncolo/oyae042
Journal:
Oncologist
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: